http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105541661-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_826e165ba3dedc056ad5b57c2847fbb4
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C253-30
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C253-30
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C255-19
filingDate 2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1d9867867911ce6cf50bb67b1ea128ef
publicationDate 2016-05-04-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber CN-105541661-A
titleOfInvention Aminopterin sodium drug intermediate cyanoacetamide synthesis method
abstract The invention relates to an aminopterin sodium drug intermediate cyanoacetamide synthesis method. The method comprises the following steps: (i) 500ml of a N-(3-hydroxyphenyl)acetamide solution is added into a reaction container mounted with a stirrer; the stirring speed is controlled at 100-160rpm, and 3.6mol of ethyl cyanoacetate is slowly added in batches; the temperature of the solution is increased to 40-45 DEG C; the stirring speed is maintained for 90-120min; the solution temperature is reduced to 5-8 DEG C, and solid is precipitated; suction filtration is carried out; an obtained solid is washed 5-7 times with a trifluoroacetic acid solution with the method described in the step (i); drying is carried out in a nitrogen atmosphere, such that light yellow solid is obtained; recrystallization is carried out with 500ml of a cyclohexane solution, such that white crystal cyanoacetamide is obtained. The mass percentage of the N-(3-hydroxyphenyl)acetamide solution in the step (i) is 65-75%.
priorityDate 2015-12-22-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID8078
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID18504529
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419525828
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID2154
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419508357
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419550149
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419522894
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID421887892
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419484729
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6422
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID12124
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID7898
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135444742
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID135398604
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID410515906
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419518250

Total number of triples: 28.